|Organic compounds -- part of the class 532-570 series patents - Monitor Patents|
USPTO Class 536 | Browse by Industry: Previous - Next | All
05/2010 | Recent | 13: May | Apr | Mar | Feb | Jan | 12: Dec | Nov | Oct | Sep | Aug | July | June | May | April | Mar | Feb | Jan | 11: Dec | Nov | Oct | Sep | Aug | Jul | Jun | May | Apr | Mar | Feb | Jan | 10: Dec | Nov | Oct | Sep | Aug | Jul | Jun | May | Apr | Mar | Feb | Jan | | 09: Dec | Nov | Oct | Sep | Aug | Jl | Jn | May | Apr | Mar | Fb | Jn | | 2008 | 2007 |
Organic compounds -- part of the class 532-570 series May archived by USPTO category 05/10Below are recently published patent applications awaiting approval from the USPTO. Recent week's RSS XML file available below.
Listing for abstract view: USPTO application #, Title, Abstract excerpt,Patent Agent. Listing format for list view: USPTO National Class full category number, title of the patent application. 05/27/2010 > patent applications in patent subcategories. archived by USPTO category
20100130732 - System and method for processing target material: A system for processing a target material includes; a cartridge which stores a material which reacts with the target material, and may include at least one chamber and at least one valve connected to the at least one chamber, a first module which may be loaded with the at least... Agent: Cantor Colburn, LLP
20100130733 - Luminescent metal ion complexes: The present invention provides luminescent metal ion complexes for use in a wide range of biological and chemical studies. The luminescent metal ion complexes of the invention comprise a metal ion chelating component covalently bound to a carrier molecule. Also provided are methods of making and using the luminescent metal... Agent: Morgan, Lewis & Bockius LLP (sf)
20100130734 - Process for preparing capecitabine: There is provided processes for the preparation of capecitabine and intermediates thereof.... Agent: Dr. Reddy''s Laboratories, Inc.
20100130735 - Antiviral nucleosides: 4-Amino-1-((2R,3S,4S,5R)-5-azido-4-hydroxy-5-hydroxymethyl-3-methyl-tetrahydro-furan-2-yl)-1H-pyrimidin-2-one (22) and prodrugs thereof are hepatitis C(HCV) polymerase inhibitors. Also disclosed are compositions and methods for inhibiting HCV and treating HCV-mediated diseases, processes for making the compounds and synthetic intermediates employed in the process.... Agent: Birch Stewart Kolasch & Birch05/20/2010 > patent applications in patent subcategories. archived by USPTO category
20100125134 - Method of separating genomic dna and plasmid dna from each other and kit therefor: Provided are a method of separating genome DNA and plasmid DNA from each other from a sample using a binding buffer containing a high concentration kosmotropic salt and chaotropic salt, and a kit therefor.... Agent: Cantor Colburn, LLP
20100125135 - Sugar production by decrystallization and hydrolysis of polysaccharide enriched biomass: Sugar solutions are obtained from polysaccharide enriched biomass by contacting biomass with water and at least one nucleophilic base to produce a polysaccharide enriched biomass comprising a solid fraction and a liquid fraction. The solid fraction is separated from the lignin-containing liquid fraction and contacted with an acid solution, the... Agent: E I Du Pont De Nemours And Company Legal Patent Records Center05/13/2010 > patent applications in patent subcategories. archived by USPTO category
20100121040 - Therapeutic agent for pain disease: Disclosed is an analgesic agent for a non-inflammatory pain disease, which comprises a sialic acid or a pharmaceutically acceptable salt thereof as an active ingredient. The sialic acid which is an active ingredient for the agent has an analgesic effect on a disease model animal of neurogenic pain which is... Agent: Oliff & Berridge, PLC
20100121041 - Method for production of sugar oxazoline derivative: Disclosed is a process for producing an oxazoline derivative from a non-protected sugar in a simple manner. Also disclosed is a process for producing a glycoside by utilizing the product of the aforementioned process. A sugar oxazoline derivative is synthesized in one step in an aqueous solution from a sugar... Agent: Hayes Soloway P.C.
20100121042 - Chimera botulinum toxin type e: The present invention relates to a toxin comprising a modified light chain of a botulinum toxin type E, wherein the modified light chain comprises amino acid sequence PFVNKQFN (SEQ ID NO: 120) at the N-terminus, and amino acid sequence xExxxLL (SEQ ID NO: 112) at the C-terminus, wherein x is... Agent: Allergan, Inc.
20100121043 - Environment-responding sirna carrier using disulfide-cross-linked polymeric micelle: Disclosed is a siRNA-encapsulating polymeric micelle complex (a polyion complex) having high monodispersibility and structural stability and excellent in the ability of transporting siRNA into a cell. Further disclosed are a nucleic acid delivery device, a nucleic acid delivery kit, a pharmaceutical composition, and a gene therapy agent, each of... Agent: Ladas & Parry LLP
20100121044 - Solid phase technique for selectively isolating nucleic acids: A method of isolating target nucleic acid molecules from a solution comprising a mixture of different size nucleic acid molecules, in the presence or absence of other biomolecules, by selectively facilitating the adsorption of a particular species of nucleic acid molecule to the functional group-coated surface of magnetically responsive paramagnetic... Agent: Hamilton, Brook, Smith & Reynolds, P.C.
20100121046 - Collecting and processing complex macromolecular mixtures: This document provides methods and materials involved in collecting and processing complex macromolecular mixtures (e.g., stool samples). For example, stool collection devices, buffers for stabilizing nucleic acid and polypeptides present in stool, and kits for using sequence-specific capture probes (e.g., nucleic acid sequences designed to hybridize with particular target nucleic... Agent: Casimir Jones, S.c.
20100121045 - Bis-modified bicyclic nucleic acid analogs: The present disclosure describes bis-modified bicyclic nucleosides and oligomeric compounds that can be prepared comprising at least one of these bis-modified bicyclic nucleosides. More particularly, the bis-modified bicyclic nucleosides have at least one substituent group at the 5′-methylene and on the bridge methylene and can be chiral. These bis-modified bicyclic... Agent: Jones Day For Isis Pharmaceuticals, Inc.
20100121047 - Methods and apparatus for hydrolyzing cellulosic material: A method of hydrolyzing woody cellulosic material containing lignin and air pockets involves impregnating the woody cellulosic material a first alkali having a pH of from 10 to 14 such that the first alkali is in contact with the lignin within the woody cellulosic material. Thereafter, the woody cellulosic material... Agent: Renner Kenner Greive Bobak Taylor & Weber05/06/2010 > patent applications in patent subcategories. archived by USPTO category
20100113757 - Novel macrolide antibiotics and their use for medical purposes: The invention provides novel Thuggacin-Type macrolide compounds which form rearrangement products forming a lacton bond to different carbon atoms. The novel compounds can be produced by fermentation of Sorangium cellulosum and Chondromyces crocatus and can be isolated by adsorption and chromoatograhic processing steps. The compounds are found to have antibiotic... Agent: Greer, Burns & Crain
20100113758 - Method for purifying biomolecules: The present invention relates to a process for the purification of biomolecules, in particular of nucleic acids, such as DNA and RNA molecules.... Agent: Baker Donelson Bearman, Caldwell & Berkowitz, PC
20100113759 - Propargyl substituted nucleoside compounds and methods: The present teachings relate to nucleobase, nucleoside and nucleotide compounds, methods of synthesis, and uses thereof. The present teachings provide compounds, such as nucleobase, nucleoside and/or nucleotide compounds including a propargyl linker, and methods for making or using such compounds.... Agent: Life Technologies Corporation C/o Intellevate
20100113761 - Sirna targeting beta secretase (bace): Efficient sequence specific gene silencing is possible through the use of siRNA technology. By selecting particular siRNAs by rational design, one can maximize the generation of an effective gene silencing reagent, as well as methods for silencing genes. Methods, compositions, and kits generated through rational design of siRNAs are disclosed... Agent: Kalow & Springut LLP
20100113760 - Sirna targeting myeloid differentiation primary response gene (88) (myd88): Efficient sequence specific gene silencing is possible through the use of siRNA technology. By selecting particular siRNAs by rational design, one can maximize the generation of an effective gene silencing reagent, as well as methods for silencing genes. Methods, compositions, and kits generated through rational design of siRNAs are disclosed... Agent: Kalow & Springut LLP
20100113762 - Apparatus and method using rotary flow distribution mechanisms: Methods and apparatus for facilitating the synthesis of compounds in a batch device are presented. Application of the batch type microfluidic devices to the synthesis of radiolabeled compounds is described. These methods and apparatus enable the selective introduction of multiple reagents via an enhanced rotary flow distribution valve through a... Agent: Siemens Corporation Intellectual Property Department
20100113763 - Method for preparation of organofluoro compounds in alcohol solvents: The present invention relates to a method for preparation of organofluoro compounds containing radioactive isotope fluorine-18. More particularly, the present invention relates to a method for preparation of organofluoro compound [18F]florbetaben or [18F]AV-45 having <Chemistry Formula 11> and <Chemistry Formula 12>, respectively, by reacting fluorine salt containing radioactive isotope fluorine-18... Agent: Lucas & Mercanti, LLP
20100113764 - Solid acid catalyzed hydrolysis of cellulosic materials: Provided are methods for the solubilization of cellulose into soluble sugars without the need for high temperatures, high pressures, strong acid solutions, and/or added water. The produced sugars can be fermented into ethanol. In one embodiment, the method comprises contacting a cellulose-containing material with a solid acid material and agitating... Agent: Timothy H. Van Dyke
20100113765 - Galactose-rich polysaccharide, process for the production of the polymer and its applications: This invention concerns a biopolymer consisting of a polysaccharide composed of galactose (50-90%), glucose (1-25%), mannose (1-25%) and rhamnose (0.5-20%), which may additionally contain, in trace amounts, xylose, fucose, ribose, arabinose and/or fructose. The galactose-rich polymer also contains non-saccharide components, namely, acyl groups. This invention also concerns a process for... Agent: Cermak Kenealy Vaidya & Nakajima LLPPrevious industry: Organic compounds -- part of the class 532-570 series
Next industry: Organic compounds -- part of the class 532-570 series
RSS FEED for 20130516:
Integrate FreshPatents.com into your RSS reader/aggregator or website to track weekly updates.
For more info, read this article.
Thank you for viewing Organic compounds -- part of the class 532-570 series patents on the FreshPatents.com website. These are patent applications which have been filed in the United States. There are a variety ways to browse Organic compounds -- part of the class 532-570 series patent applications on our website including browsing by date, agent, inventor, and industry. If you are interested in receiving occasional emails regarding Organic compounds -- part of the class 532-570 series patents we recommend signing up for free keyword monitoring by email.
FreshPatents.com Support - Terms & Conditions
Results in 0.19382 seconds